| ROBERT CLANCY is Emeritus Professor of Pathology at the University of Newcastle Medical School. He is a member of the Australian Academy of Science’s COVID-19 Expert Database. His long article "Covid-19 Where Are We Going" has been published in
Quadrant On Line.
FRAGMENT: Second, local Australian control of vaccines makes much sense. Current thinking by government encouraging local manufacture of mRNA vaccines, is to say the least, concerning and premature. The efficacy/adverse event relationship of all vaccines, as well as technical issues, must first be resolved. For many years we have guaranteed supply with local production of an antigen-based vaccine (influenza) adapted to contemporary virus mutants. At this stage data and science favour antigen vaccines over genetic vaccines. Early evidence that genetic vaccines can re-model the immune apparatus, with hypersensitivity and autoimmune complications in the short term, together with localisation of spike protein in the brain, heart and other tissues, predicts possible long-term complications involving brain, heart and other tissues. Monitoring of both adverse events and virus genotype is central to long-term vaccine strategy.
The whole expose followed by a series of most interesting comments can be found here quadrant.org.au
Yet another link:
German Professor Sucharit Bhakdi.Listen as it is still available! | 
